Ayala Pharmaceuticals Inc (ADXS)

[exel_mm]

Looks like EU approval, at best, not happening until late 2018 based on what I just saw and heard from the presentation. This resets my BO prognosis into 2019, at the earliest.

Given this, I would be surprised if we have a partner queued for Europe right now. This means the pps will likely tread water for the next few months unless other material events transpire.